Mentice Introduces Software Subscription for its VIST® Endovascular Simulation Platform

Northwell Health Ranked Nation’s Top Health System for Diversity

New York State’s largest health care provider and private employer made the list for the ninth straight year and remained in the top spot in the 2021 DiversityInc rankings for Hospitals and Health Systems.

ZAP Surgical and Swiss Neuro Radiosurgery Center Announce Imminent Installation of New Gyroscopic Radiosurgery Platform for Treating Brain Tumors

ZAP-X is also the first and only dedicated radiosurgery system to no longer require Cobalt-60 radioactive sources, thus eliminating the significant costs to license, secure and regularly replace live radioactive isotopes.

Kathy Sherwood Joins Pelvital USA, Inc. Board of Directors

Sherwood's experience, which includes a diverse group of medical product companies such as Boston Scientific, American Medical Systems, St. Jude Medical, Kinetic Concepts, Transoma Medical and Medtronic, gives her an understanding of the problems faced by both large and small companies.

Today Mentice AB (STO: MNTC) (simulation solutions for endovascular therapies) announced  the introduction of software subscription for its VIST® endovascular simulation platform to hospitals and health systems. By significantly reducing the upfront capital expenditure and introducing an annual software subscription, Mentice now enables clients around the world to rapidly deploy the VIST® platform under a transparent, flexible, and predictable model.

“With global health systems and hospitals experiencing significant pressures to improve productivity, reduce costs, and improve patient outcomes, we remain laser-focused on our quest to help improve endovascular procedure performance and patient outcomes through simulation,” said Göran Malmberg, CEO at Mentice. “While our VIST® platform helps our clients improve their clinical performance, the introduction of software subscription on our training modules aligns Mentice to the financial realities of a clinical practice helping our clients operationalize costs to better manage their financial performance.”

The VIST® software subscription offers Mentice clients flexible procedure selection and predictable annual pricing while it includes software updates, it eliminates hidden service support costs, and it scales based on customer need.

In addition to lower cost of entry and software updates, software subscription for the VIST® platform includes complimentary trial of new procedures, ability to exchange procedures as client-needs change, and access to a global team of software and hardware support experts.

This is the first and a significant step into Mentice’s plans to advance the value of endovascular simulation for clients worldwide.



Subscribe to Medical Device News Magazine here.

Related Articles